期刊文献+

品管圈活动应用于糖尿病肾病血液透析患者护理中的价值研究

Study on the Value of Quality Control Circle Activity in the Care of Patients with Diabetic Nephropathy Hemodialysis
下载PDF
导出
摘要 目的 探索品管圈活动应用于糖尿病肾病血液透析患者护理中的价值.方法 2017年9月—2018年9月选择120例糖尿病肾病血液透析患者为试验对象,选择抓阄随机化分组,各60例,分别选择品管圈活动、常规护理,随后对比两组血糖值改善情况以及并发症发生率、WHOQOL-100量表评分.结果 观察组WHOQOL-100量表评分(84.74±3.78)分高于对照组,并发症发生率(1.67%)、空腹血糖(5.43±0.17)mmol/L、餐后2 h血糖(7.43±1.96)mmol/L、糖化血红蛋白(6.41±0.53)%低于对照组(P<0.05).结论 对糖尿病肾病血液透析患者实施品管圈活动护理效果显著,可改善血糖值,降低并发症发生率. Objective To explore the value of quality control circle activities in the care of patients with diabetic nephropathy hemodialysis.Methods From Sept 2017 to Sept 2018 select 120 cases of hemodialysis patients with diabetic nephropathy as the test object,choose randomized grouping of 60 people,respectively,choose quality control circle activities and routine care,and then compare the improvement of blood glucose value and the incidence of complications,WHOQOL-100 scale rating.Results The observation group WHOQOL-100 scale score(84.74±3.78)points was higher than the control group,the incidence of complications(1.67%),fasting blood glucose(5.43±0.17)mmol/L,2 hours postprandial blood glucose(7.43±1.96)mmol/L,glycated hemoglobin(6.41±0.53)%is lower than the control group(P<0.05).Conclusion Carrying out quality nursing care for diabetic nephropathy hemodialysis patients has a significant effect,which can improve blood glucose level and reduce the incidence of complications.
作者 林雅凤 陆丽娜 范良月 LIN Ya-feng;LU Li-na;FAN Liang-yue(Blood Purification Center,Ningde City Hospital,Fujian Medical University,Ningde,Fujian Province,352100 China)
出处 《糖尿病新世界》 2020年第11期137-139,共3页 Diabetes New World Magazine
关键词 品管圈活动 糖尿病肾病 血液透析 护理 Quality control circle activity Diabetic nephropathy Hemodialysis Nursing
  • 相关文献

二级参考文献67

  • 1Parikh R, Pandia K, Goyal M, et al. Trend of elinical drug trials in type 2 diabetes mellitus over last decade[J] . Perspeet ClinRes, 2011, 2 (2): 64-66.
  • 2Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas:global estimates of the prevalence of diabetes for 2011 and 2030 [J] . Diabetes Res Clin Pract, 2011, 94 (3) : 311-321.
  • 3Gray SP, Cooper ME. Diabetic nephropathy in 2010: Allevia- ting the burden of diabetic nephropathy [J] . Nat Rev Neph- rol, 2011, 7 (2): 71-73.
  • 4Jia Z, Sun Y, Yang G, et al. New insights into the PPAR agonists for the treatment of diabetic nephropathy [J] . PPAR Res, 2014, 2014: 818530.
  • 5Mizutani K, Park K, Mima A, et al. Obesity-assoeiated gin- gival vascular inflammation and insulin resistance[J] . J Dent Res, 2014, 93 (6): 596-601.
  • 6Soetikno V, Arozal W, Louisa M1, et al. New insight into the molecular drag target of diabetic nephropathy [J] . Int J Endo- erinol, 2014, 2014: 968681.
  • 7Impellizzeri D, Esposito E, Attley J, et al. Targeting inflam- mation: new therapeutic approaches in chronic kidney disease (CKD) [J] .PharmacolRes, 2014, 81: 91-102.
  • 8许敏玲,袁帅,丁德良.糖尿病肾病不同进展阶段的微炎症状态及其干预治疗研究[J].解剖学研究,2010,32(2):121-125. 被引量:17
  • 9胡杨青,颜伟健,周巧玲.血液透析联合血液灌流对维持性血液透析患者微炎症与营养状况的影响[J].中国血液净化,2010,9(12):672-674. 被引量:18
  • 10叶婷婷,邓妍妍,田少江,李骏峰,刘涛,刘滇军,沈建明.金水宝胶囊改善糖尿病肾病维持性血液透析患者细胞免疫功能疗效观察[J].现代中西医结合杂志,2012,21(4):400-401. 被引量:11

共引文献130

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部